On the other hand, FNDC5/irisin levels are diminished in people with obesity, hepatic steatosis, metabolic syndrome, and type 2 diabetes mellitus (Bonfante et al., 2017). Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.